Monthly News Roundup - February 2025
FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy Izervay (avacincaptad pegol) from Astellas is now FDA-approved without a limitation on duration of dosing, allowing greater flexibility when managing Geographic Atrophy...
FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy
Izervay (avacincaptad pegol) from Astellas is now FDA-approved without a limitation on duration of dosing, allowing greater flexibility when managing Geographic Atrophy...
